about
Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in TanzaniaHigh-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in TanzaniaMolecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in TanzaniaMonitoring parasite diversity for malaria elimination in sub-Saharan AfricaSurveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the Lake and Southern Zones, Tanzania, using pooling and next-generation sequencing.Independent origin of plasmodium falciparum antifolate super-resistance, Uganda, Tanzania, and Ethiopia.Engaging diverse communities participating in clinical trials: case examples from across Africa.Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern TanzaniaUsing rapid diagnostic tests as source of malaria parasite DNA for molecular analyses in the era of declining malaria prevalence.Users' and health service providers' perception on quality of laboratory malaria diagnosis in Tanzania.Spatial variation and socio-economic determinants of Plasmodium falciparum infection in northeastern TanzaniaAccuracy of malaria rapid diagnostic tests in community studies and their impact on treatment of malaria in an area with declining malaria burden in north-eastern Tanzania.Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.The readiness of the national health laboratory system in supporting care and treatment of HIV/AIDS in Tanzania.Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.IgG antibodies to endothelial protein C receptor-binding cysteine-rich interdomain region domains of Plasmodium falciparum erythrocyte membrane protein 1 are acquired early in life in individuals exposed to malaria.Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in InfantsGenetic determinants of anti-malarial acquired immunity in a large multi-centre studyPerformance of health laboratories in provision of HIV diagnostic and supportive services in selected districts of Tanzania.Using community-owned resource persons to provide early diagnosis and treatment and estimate malaria burden at community level in north-eastern Tanzania.K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa.Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania.Declining burden of malaria over two decades in a rural community of Muheza district, north-eastern Tanzania.Deployment and use of mobile phone technology for real-time reporting of fever cases and malaria treatment failure in areas of declining malaria transmission in Muheza district north-eastern TanzaniaDifferent origin and dispersal of sulfadoxine-resistant Plasmodium falciparum haplotypes between Eastern Africa and Democratic Republic of Congo.Relationships between sickle cell trait, malaria, and educational outcomes in Tanzania.Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.Randomised controlled trial of two sequential artemisinin-based combination therapy regimens to treat uncomplicated falciparum malaria in African children: a protocol to investigate safety, efficacy and adherence.Malaria specific mortality in lowlands and highlands of Muheza district, north-eastern Tanzania.Capacity Development through the US President's Malaria Initiative-Supported Antimalarial Resistance Monitoring in Africa Network.Pattern of all-causes and cause-specific mortality in an area with progressively declining malaria burden in Korogwe district, north-eastern Tanzania.Comparison of visual and automated Deki Reader interpretation of malaria rapid diagnostic tests in rural Tanzanian military health facilities.Trends of Plasmodium falciparum prevalence in two communities of Muheza district North-eastern Tanzania: correlation between parasite prevalence, malaria interventions and rainfall in the context of re-emergence of malaria after two decades of progrDeployment and utilization of next-generation sequencing of Plasmodium falciparum to guide anti-malarial drug policy decisions in sub-Saharan Africa: opportunities and challenges
P50
Q26820807-14CE8684-E842-45EC-8A58-C34EA405C5E7Q28125930-5C7D0A76-41A5-45DF-9EDC-0A6934C9C611Q28125938-0F9FE0EC-2D5C-42C8-9447-1C7361F00698Q28610494-35C320E7-5725-441B-969D-C5E61326ED34Q33767971-E5858D4F-BBEC-4C2E-A540-2CB2CFF525DDQ33950981-0C8FE0E9-5B5F-4C06-839C-97A6582415F2Q34010897-3C18CD1E-D692-4172-AEE9-A0558FE3B416Q34253706-6901B1C4-4F88-4CAA-B043-24DB3A21A57FQ34515760-AD37D485-81E7-498D-98EF-D3229CCB700BQ34881880-516183FC-EAFA-4B06-98FA-AA3BFE1CC5E4Q35068274-A0764C6D-76B9-4004-AD79-C2C592C12390Q35133809-80092FFC-A06F-42ED-B570-318859C28830Q35576130-5975460A-CF2E-4032-8897-354A985D24FDQ35675056-61BE9FC8-2E00-4BA7-BE20-F3BAE9F140ACQ35830639-A3D824DE-5EFA-4D6A-8946-1EA43C7E6FCDQ35833840-627F56A4-44DF-4F68-BA35-7445171483C5Q35850290-A6E22B35-EDE9-4D46-AC85-AF1994F18B88Q36004135-D577D04F-32FA-41CF-BE2A-577E47138131Q36258077-01C0BB51-380F-4240-8F09-19D82A844A39Q36453649-54EDEEDD-C9BB-446D-A9FA-639BB545564BQ36786733-0DCC05AF-77E6-444D-99C2-5FD55F634CB5Q37289589-57BF3FE5-9E5D-4E4E-A096-0948FDA60888Q37363924-E98D1EE6-4ABC-4A85-926C-7B09B972BB72Q38648354-3C84FD07-C988-4B3B-958F-14FDB670364DQ38851115-63C00751-AF05-42F6-8FFC-5B7600C165B9Q40043244-F6F936B4-478F-4BAF-BF6F-A0E5E0924343Q41938717-ED02FD83-64FC-4A79-AE8F-B9D2696EB6C4Q43923927-9142871B-DCE4-4D2C-AC95-938989E43F34Q43945720-7E5DD451-F046-4B97-9D32-F243E63FA039Q46946651-7E57412D-F4F1-4F5A-ADC4-887F9FD9774CQ55034809-84EA7DFD-B6CA-4DCB-8A5D-894CEB46B526Q55114358-00D6A19E-4890-4316-B0FB-316269C47A56Q55541304-5B4D0F4D-EFD7-4611-9961-D869A997AAB3Q93060304-C3E231BF-4A6D-4AC7-9F67-F82B453D08F2
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Deus S Ishengoma
@ast
Deus S Ishengoma
@en
Deus S Ishengoma
@es
Deus S Ishengoma
@nl
Deus S Ishengoma
@sl
type
label
Deus S Ishengoma
@ast
Deus S Ishengoma
@en
Deus S Ishengoma
@es
Deus S Ishengoma
@nl
Deus S Ishengoma
@sl
prefLabel
Deus S Ishengoma
@ast
Deus S Ishengoma
@en
Deus S Ishengoma
@es
Deus S Ishengoma
@nl
Deus S Ishengoma
@sl
P106
P31
P496
0000-0003-2040-3416